Free Trial

American Healthcare REIT (NYSE:AHR) Now Covered by Analysts at Robert W. Baird

American Healthcare REIT logo with Finance background

Investment analysts at Robert W. Baird began coverage on shares of American Healthcare REIT (NYSE:AHR - Get Free Report) in a report issued on Friday, Marketbeat.com reports. The brokerage set an "outperform" rating and a $41.00 price target on the stock. Robert W. Baird's price objective would suggest a potential upside of 8.77% from the company's current price.

Several other brokerages have also recently commented on AHR. Jefferies Financial Group started coverage on American Healthcare REIT in a research report on Monday, April 28th. They issued a "buy" rating and a $37.00 target price for the company. Morgan Stanley raised their target price on American Healthcare REIT from $37.00 to $45.00 and gave the stock an "overweight" rating in a research report on Tuesday, May 20th. Truist Financial raised their target price on American Healthcare REIT from $32.00 to $38.00 and gave the stock a "buy" rating in a research report on Monday, June 9th. Scotiabank started coverage on American Healthcare REIT in a research report on Monday, June 30th. They issued a "sector outperform" rating and a $42.00 target price for the company. Finally, KeyCorp lifted their price objective on American Healthcare REIT from $34.00 to $40.00 and gave the company an "overweight" rating in a report on Wednesday, June 11th. Ten research analysts have rated the stock with a buy rating, According to MarketBeat, the stock currently has a consensus rating of "Buy" and an average price target of $38.11.

Get Our Latest Stock Report on AHR

American Healthcare REIT Stock Performance

AHR stock traded up $0.43 during midday trading on Friday, hitting $37.69. 76,294 shares of the company traded hands, compared to its average volume of 1,888,682. American Healthcare REIT has a twelve month low of $14.79 and a twelve month high of $37.71. The company has a quick ratio of 0.38, a current ratio of 0.38 and a debt-to-equity ratio of 0.45. The business has a 50 day simple moving average of $35.64 and a 200-day simple moving average of $31.49. The stock has a market capitalization of $6.01 billion, a price-to-earnings ratio of -139.59, a price-to-earnings-growth ratio of 2.10 and a beta of 1.09.

American Healthcare REIT (NYSE:AHR - Get Free Report) last posted its quarterly earnings data on Thursday, May 8th. The company reported $0.38 earnings per share for the quarter, beating the consensus estimate of $0.37 by $0.01. American Healthcare REIT had a negative return on equity of 1.85% and a negative net margin of 1.96%. The company had revenue of $540.60 million during the quarter, compared to analysts' expectations of $542.32 million. During the same period in the prior year, the business earned $0.30 earnings per share. American Healthcare REIT's revenue for the quarter was up 8.2% compared to the same quarter last year. As a group, equities research analysts predict that American Healthcare REIT will post 1.41 earnings per share for the current year.

Insiders Place Their Bets

In other American Healthcare REIT news, CIO Stefan K.L. Oh sold 3,860 shares of the business's stock in a transaction dated Monday, June 30th. The stock was sold at an average price of $36.10, for a total transaction of $139,346.00. Following the completion of the sale, the executive directly owned 95,671 shares of the company's stock, valued at approximately $3,453,723.10. The trade was a 3.88% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Corporate insiders own 0.92% of the company's stock.

Institutional Trading of American Healthcare REIT

Several institutional investors and hedge funds have recently added to or reduced their stakes in AHR. Wolff Wiese Magana LLC bought a new stake in American Healthcare REIT during the 1st quarter worth about $25,000. MassMutual Private Wealth & Trust FSB grew its position in shares of American Healthcare REIT by 189.0% during the 1st quarter. MassMutual Private Wealth & Trust FSB now owns 968 shares of the company's stock worth $29,000 after buying an additional 633 shares during the period. Spirit of America Management Corp NY acquired a new position in shares of American Healthcare REIT during the 1st quarter worth about $30,000. Physician Wealth Advisors Inc. acquired a new position in shares of American Healthcare REIT during the 2nd quarter worth about $34,000. Finally, Avalon Trust Co acquired a new position in shares of American Healthcare REIT during the 1st quarter worth about $36,000. 16.68% of the stock is owned by institutional investors.

American Healthcare REIT Company Profile

(Get Free Report)

Formed by the successful merger of Griffin-American Healthcare REIT III and Griffin-American Healthcare REIT IV, as well as the acquisition of the business and operations of American Healthcare Investors, American Healthcare REIT is one of the larger healthcare-focused real estate investment trusts globally with assets totaling approximately $4.2 billion in gross investment value.

Featured Articles

Analyst Recommendations for American Healthcare REIT (NYSE:AHR)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in American Healthcare REIT Right Now?

Before you consider American Healthcare REIT, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and American Healthcare REIT wasn't on the list.

While American Healthcare REIT currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

This Strategy Beat the S&P—And Most Investors Ignore It
NVDA Greenlight: China Sales Spark 50% Rally Potential
Time to Cash Out? 5 Stocks to Drop Before Earnings

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines